A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
Bristol-Myers Squibb
Washington University School of Medicine
NYU Langone Health
Second Affiliated Hospital, School of Medicine, Zhejiang University
NRG Oncology
Tianjin Medical University Cancer Institute and Hospital
Jonsson Comprehensive Cancer Center
University of California, San Francisco
ZSky Biotech Inc
Everfront Biotech Co., Ltd.
University of California, San Francisco
Centre Hospitalier Universitaire de Besancon
Tianjin Medical University Cancer Institute and Hospital
AHS Cancer Control Alberta
NeuGATE Theranostics
Alliance for Clinical Trials in Oncology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Philogen S.p.A.
Peking University People's Hospital
Tongji Hospital
Olympion Medical Center
Huashan Hospital
Sun Yat-sen University
Istituto Clinico Humanitas
Institut de cancérologie Strasbourg Europe
Southern Medical University, China